We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Medtronic
MDT
$116B
| $563K | ﹤0.01% |
6,984
-54,824
| -89% | -$4.47M |
|
|
TPIC
827
DELISTED
TPI Composites
TPIC
| $561K | ﹤0.01% |
42,989
-21,994
| -34% | -$280K |
|
828
Arthur J. Gallagher & Co
AJG
$65B
| $555K | ﹤0.01% |
2,903
-55
| -2% | -$10.4K |
|
829
Teekay
TK
$1.06B
| $548K | ﹤0.01% |
+88,680
| New | +$474K |
|
|
AGEN
830
Agenus
AGEN
$315M
| $548K | ﹤0.01% |
18,367
-7,307
| -28% | -$309K |
|
831
Financial Institutions
FISI
$825M
| $547K | ﹤0.01% |
28,358
-880
| -3% | -$20.6K |
|
832
Aflac
AFL
$60.7B
| $544K | ﹤0.01% |
8,439
+1,239
| +17% | +$84.8K |
|
833
AXT Inc
AXTI
$5.07B
| $544K | ﹤0.01% |
136,670
-3,190
| -2% | -$15.5K |
|
834
ITT
ITT
$19.4B
| $541K | ﹤0.01% |
6,273
+3,240
| +107% | +$285K |
|
835
Vir Biotechnology
VIR
$1.52B
| $541K | ﹤0.01% |
23,257
-39,668
| -63% | -$1.01M |
|
836
The RMR Group
RMR
$346M
| $536K | ﹤0.01% |
20,442
-14,171
| -41% | -$397K |
|
837
Napco Security Technologies
NSSC
$1.37B
| $527K | ﹤0.01% |
+14,026
| New | +$447K |
|
838
Innospec
IOSP
$2.31B
| $526K | ﹤0.01% |
5,124
-723
| -12% | -$77.8K |
|
839
Liberty Energy
LBRT
$3.45B
| $525K | ﹤0.01% |
40,967
+29,441
| +255% | +$436K |
|
|
CFB
840
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $524K | ﹤0.01% |
50,045
-10,100
| -17% | -$129K |
|
841
Orthofix Medical
OFIX
$415M
| $524K | ﹤0.01% |
+31,285
| New | +$612K |
|
|
TMHC
842
DELISTED
Taylor Morrison
TMHC
| $521K | ﹤0.01% |
13,621
+3,642
| +36% | +$128K |
|
843
Peapack-Gladstone Financial
PGC
$822M
| $520K | ﹤0.01% |
17,547
-450
| -3% | -$15.9K |
|
844
Federated Hermes
FHI
$4.74B
| $518K | ﹤0.01% |
12,901
-1,300
| -9% | -$51K |
|
845
RBB Bancorp
RBB
$466M
| $517K | ﹤0.01% |
33,360
-4,990
| -13% | -$95.5K |
|
846
Sprouts Farmers Market
SFM
$7.71B
| $515K | ﹤0.01% |
14,709
-1,621
| -10% | -$52.5K |
|
847
Rigel Pharmaceuticals
RIGL
$762M
| $514K | ﹤0.01% |
38,913
-1,246
| -3% | -$19.8K |
|
848
ePlus
PLUS
$2.31B
| $513K | ﹤0.01% |
10,451
-140
| -1% | -$7.1K |
|
849
McGrath RentCorp
MGRC
$2.94B
| $510K | ﹤0.01% |
+5,468
| New | +$541K |
|
850
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $510K | ﹤0.01% |
21,526
-1,962
| -8% | -$58.4K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.